Clinical Trial: (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869732) titled '(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty' on Oct. 06.

Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, and blood levels of (Z)-endoxifen in girls with McCune-Albright Syndrome that have peripheral precocious puberty. The main question it aims to answer [is/are]:

Are there any safety concerns? Is there any evidence of efficacy?

There is no comparison group.

Participants will:

* take a capsule once a day for 3 months;

* have doctor visits (tele-health and in-person);

* blood samples collected; and

* complete questionnaires

Study Start Date: March, 2027

Stu...